Semaglutide Dosage Guide

Complete guide to Semaglutide dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Wegovy (weight loss): Start at 0.25mg weekly, titrate up to 2.4mg weekly over 16-20 weeks. Ozempic (diabetes): 0.25mg to 1mg weekly. Research protocols vary.

Administration Method

Subcutaneous injection once weekly, typically in abdomen, thigh, or upper arm. Rybelsus is taken orally on empty stomach. Dose titration is essential to minimize GI side effects.

Side Effects to Monitor

Common: nausea, vomiting, diarrhea, constipation, abdominal pain. These typically decrease over time. May cause injection site reactions.

Safety Considerations & Risks

Contraindicated with personal/family history of medullary thyroid carcinoma or MEN2 syndrome. Risk of pancreatitis, gallbladder disease, and potential retinopathy progression in diabetics.